Error: Could not add to watchlist. X

Rydex Series - Small Cap Growth

+ Watchlist
RYSGX:US
NASDAQ GM
45.58
USD
0.07
0.15%
As of 8:01 PM EST on 2/9/2016.
Fund Type
Open-End Fund
52Wk Range
45.51 - 61.81
1 Yr Return
-17.52%
YTD Return
-14.93%
Open
45.58
Day Range
45.58 - 45.58
Previous Close
45.51
52Wk Range
45.51 - 61.81
1 Yr Return
-16.73%
YTD Return
-14.93%
Fund Type
Open-End Fund
Objective
Growth Small Cap
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 02/09/2016)
45.58
Total Assets (m USD) (on 02/09/2016)
21.975
Inception Date
09/01/2004
Last Dividend (on 11/28/2007)
0.9387
Dividend Indicated Gross Yield
-
Fund Managers
MICHAEL PAUL BYRUM / RYAN A HARDER
Front Load Fee
4.75%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.25%
Current Mgmt Fee
0.75%
Expense Ratio
1.52%
Top Fund Holdings
Name Position Value % of Fund
Ligand Pharmaceuticals Inc 5.66 k 613.12 k 1.74
PGT Inc 43.79 k 498.71 k 1.42
ABIOMED Inc 5.43 k 490.49 k 1.39
First Midwest Bancorp Inc/IL 23.55 k 434.03 k 1.23
Meritage Homes Corp 12.30 k 418.11 k 1.19
Supernus Pharmaceuticals Inc 30.23 k 406.22 k 1.15
MiMedx Group Inc 42.64 k 399.55 k 1.13
LogMeIn Inc 5.95 k 399.18 k 1.13
LendingTree Inc 4.43 k 395.51 k 1.12
Cross Country Healthcare Inc 24.00 k 393.36 k 1.12
Profile
Rydex Series - Small Cap Growth is an open-end fund incorporated in the USA. The Fund objective is to provide investment results that match the performance of a benchmark for small cap growth securities. The Fund invests at least 80% of its assets in securities of companies in the underlying index and derivatives and other instruments whose performance is expected to correspond to the index.
ADDRESS
Rydex Funds
9601 Blackwell Road
Suite 500
Rockville, MD 20850
PHONE
1-301-296-5100